285
Participants
Start Date
January 31, 2013
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Degarelix
Goserelin
Cancer Institute & Hospital. Chinese Academy of Medical Sciences, Beijing
Affiliated Southwest Hospital of 3rd Military Medical University of People's Liberation Army, Chongqing
1st Afilliated Hospital of Guangzhou Medical College, Guangzhou
Renmin Hospital of Wuhan University, Wuhan
2nd.Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi’an
1st Hospital Affiliated to Zhejiang University Medical School, Hangzhou
Beijing Hospital of Ministry of Health, Beijing
Peking Union Hospital, Beijing
Peking University 3rd Hospital, Beijing
Peking University People's Hospital, Beijing
1st Hospital of Jilin University, Changchun
Hunan Cancer Hospital, Changsha
Hunan Province People's Hospital, Changsha
People's Hospital of Sichuan, Chengdu
2nd Hospital Affiliated to Zhejiang University Medical School, Hangzhou
1st Hospital of Lanzhou University, Lanzhou
1st Affiliated Hospital of Nanchang University, Nanchang
1st Affiliated Hospital of Nanjing Medical University, Nanjing
Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing
Fudan University Shanghai Cancer Center, Shanghai
Huashan Hospital of Fudan University, Shanghai
Shanghai 5th People's Hospital affilicated to Fudan University, Shanghai
Shanghai Changhai Hospital, Shanghai
1st Hospital Affiliated to China Medical University, Shenyang
2nd Hospital Affiliated to Suzhou University, Suzhou
2nd Hospital of Tianjin Medical University, Tianjin
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Zhongnan Hospital of Wuhan University, Wuhan
1st People's Hospital of Wuxi, Wuxi
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY